The Neuropad test

A visual indicator test for human diabetic neuropathy

C. Quattrini, M. Jeziorska, M. Tavakoli, P. Begum, A. J M Boulton, Rayaz Malik

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Aims/hypothesis: The commercially available Neuropad test was developed as a simple visual indicator test to evaluate diabetic neuropathy. It uses a colour change to define the integrity of skin sympathetic cholinergic innervation. We compared the results of Neuropad assessment in the foot with established measures of somatic and autonomic neuropathy. Methods: Fifty-seven diabetic patients underwent Neuropad assessment, quantitative sensory and autonomic function testing, and evaluation of intra-epidermal nerve fibre density in foot skin biopsies. Results: Neuropad responses correlated with the neuropathy disability score (rs=0.450, p<0.001), neuropathic symptom score (rs=0.288, p=0.03), cold detection threshold (rs=0.394, p=0.003), heat-as-pain perception threshold visual analogue score 0.5 (r s=0.279, p=0.043) and deep-breathing heart rate variability (r s=-0.525, p<0.001). Intra-epidermal nerve fibre density (fibres/mm) compared with age- and sex-matched control subjects (11.06±0.82) was non-significantly reduced (7.37±0.93) in diabetic patients with a normal Neuropad response and significantly reduced in patients with a patchy (5.01±0.93) or absent (5.02±0.77) response (p=0.02). The sensitivity of an abnormal Neuropad response in detecting clinical neuropathy (neuropathy disability score ≥5) was 85% (negative predictive value 71%) and the specificity was 45% (positive predictive value 69%). Conclusions/interpretation: The Neuropad test may be a simple indicator for screening patients with diabetic neuropathy.

Original languageEnglish
Pages (from-to)1046-1050
Number of pages5
JournalDiabetologia
Volume51
Issue number6
DOIs
Publication statusPublished - Jun 2008
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Nerve Fibers
Foot
Skin
Pain Perception
Pain Threshold
Cholinergic Agents
Respiration
Color
Hot Temperature
Heart Rate
Biopsy

Keywords

  • Autonomic neuropathy
  • Diabetic neuropathy
  • Skin innervation
  • Sudomotor dysfunction

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Quattrini, C., Jeziorska, M., Tavakoli, M., Begum, P., Boulton, A. J. M., & Malik, R. (2008). The Neuropad test: A visual indicator test for human diabetic neuropathy. Diabetologia, 51(6), 1046-1050. https://doi.org/10.1007/s00125-008-0987-y

The Neuropad test : A visual indicator test for human diabetic neuropathy. / Quattrini, C.; Jeziorska, M.; Tavakoli, M.; Begum, P.; Boulton, A. J M; Malik, Rayaz.

In: Diabetologia, Vol. 51, No. 6, 06.2008, p. 1046-1050.

Research output: Contribution to journalArticle

Quattrini, C, Jeziorska, M, Tavakoli, M, Begum, P, Boulton, AJM & Malik, R 2008, 'The Neuropad test: A visual indicator test for human diabetic neuropathy', Diabetologia, vol. 51, no. 6, pp. 1046-1050. https://doi.org/10.1007/s00125-008-0987-y
Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJM, Malik R. The Neuropad test: A visual indicator test for human diabetic neuropathy. Diabetologia. 2008 Jun;51(6):1046-1050. https://doi.org/10.1007/s00125-008-0987-y
Quattrini, C. ; Jeziorska, M. ; Tavakoli, M. ; Begum, P. ; Boulton, A. J M ; Malik, Rayaz. / The Neuropad test : A visual indicator test for human diabetic neuropathy. In: Diabetologia. 2008 ; Vol. 51, No. 6. pp. 1046-1050.
@article{05cd59b63bcd4c908d21315de17a4d86,
title = "The Neuropad test: A visual indicator test for human diabetic neuropathy",
abstract = "Aims/hypothesis: The commercially available Neuropad test was developed as a simple visual indicator test to evaluate diabetic neuropathy. It uses a colour change to define the integrity of skin sympathetic cholinergic innervation. We compared the results of Neuropad assessment in the foot with established measures of somatic and autonomic neuropathy. Methods: Fifty-seven diabetic patients underwent Neuropad assessment, quantitative sensory and autonomic function testing, and evaluation of intra-epidermal nerve fibre density in foot skin biopsies. Results: Neuropad responses correlated with the neuropathy disability score (rs=0.450, p<0.001), neuropathic symptom score (rs=0.288, p=0.03), cold detection threshold (rs=0.394, p=0.003), heat-as-pain perception threshold visual analogue score 0.5 (r s=0.279, p=0.043) and deep-breathing heart rate variability (r s=-0.525, p<0.001). Intra-epidermal nerve fibre density (fibres/mm) compared with age- and sex-matched control subjects (11.06±0.82) was non-significantly reduced (7.37±0.93) in diabetic patients with a normal Neuropad response and significantly reduced in patients with a patchy (5.01±0.93) or absent (5.02±0.77) response (p=0.02). The sensitivity of an abnormal Neuropad response in detecting clinical neuropathy (neuropathy disability score ≥5) was 85{\%} (negative predictive value 71{\%}) and the specificity was 45{\%} (positive predictive value 69{\%}). Conclusions/interpretation: The Neuropad test may be a simple indicator for screening patients with diabetic neuropathy.",
keywords = "Autonomic neuropathy, Diabetic neuropathy, Skin innervation, Sudomotor dysfunction",
author = "C. Quattrini and M. Jeziorska and M. Tavakoli and P. Begum and Boulton, {A. J M} and Rayaz Malik",
year = "2008",
month = "6",
doi = "10.1007/s00125-008-0987-y",
language = "English",
volume = "51",
pages = "1046--1050",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - The Neuropad test

T2 - A visual indicator test for human diabetic neuropathy

AU - Quattrini, C.

AU - Jeziorska, M.

AU - Tavakoli, M.

AU - Begum, P.

AU - Boulton, A. J M

AU - Malik, Rayaz

PY - 2008/6

Y1 - 2008/6

N2 - Aims/hypothesis: The commercially available Neuropad test was developed as a simple visual indicator test to evaluate diabetic neuropathy. It uses a colour change to define the integrity of skin sympathetic cholinergic innervation. We compared the results of Neuropad assessment in the foot with established measures of somatic and autonomic neuropathy. Methods: Fifty-seven diabetic patients underwent Neuropad assessment, quantitative sensory and autonomic function testing, and evaluation of intra-epidermal nerve fibre density in foot skin biopsies. Results: Neuropad responses correlated with the neuropathy disability score (rs=0.450, p<0.001), neuropathic symptom score (rs=0.288, p=0.03), cold detection threshold (rs=0.394, p=0.003), heat-as-pain perception threshold visual analogue score 0.5 (r s=0.279, p=0.043) and deep-breathing heart rate variability (r s=-0.525, p<0.001). Intra-epidermal nerve fibre density (fibres/mm) compared with age- and sex-matched control subjects (11.06±0.82) was non-significantly reduced (7.37±0.93) in diabetic patients with a normal Neuropad response and significantly reduced in patients with a patchy (5.01±0.93) or absent (5.02±0.77) response (p=0.02). The sensitivity of an abnormal Neuropad response in detecting clinical neuropathy (neuropathy disability score ≥5) was 85% (negative predictive value 71%) and the specificity was 45% (positive predictive value 69%). Conclusions/interpretation: The Neuropad test may be a simple indicator for screening patients with diabetic neuropathy.

AB - Aims/hypothesis: The commercially available Neuropad test was developed as a simple visual indicator test to evaluate diabetic neuropathy. It uses a colour change to define the integrity of skin sympathetic cholinergic innervation. We compared the results of Neuropad assessment in the foot with established measures of somatic and autonomic neuropathy. Methods: Fifty-seven diabetic patients underwent Neuropad assessment, quantitative sensory and autonomic function testing, and evaluation of intra-epidermal nerve fibre density in foot skin biopsies. Results: Neuropad responses correlated with the neuropathy disability score (rs=0.450, p<0.001), neuropathic symptom score (rs=0.288, p=0.03), cold detection threshold (rs=0.394, p=0.003), heat-as-pain perception threshold visual analogue score 0.5 (r s=0.279, p=0.043) and deep-breathing heart rate variability (r s=-0.525, p<0.001). Intra-epidermal nerve fibre density (fibres/mm) compared with age- and sex-matched control subjects (11.06±0.82) was non-significantly reduced (7.37±0.93) in diabetic patients with a normal Neuropad response and significantly reduced in patients with a patchy (5.01±0.93) or absent (5.02±0.77) response (p=0.02). The sensitivity of an abnormal Neuropad response in detecting clinical neuropathy (neuropathy disability score ≥5) was 85% (negative predictive value 71%) and the specificity was 45% (positive predictive value 69%). Conclusions/interpretation: The Neuropad test may be a simple indicator for screening patients with diabetic neuropathy.

KW - Autonomic neuropathy

KW - Diabetic neuropathy

KW - Skin innervation

KW - Sudomotor dysfunction

UR - http://www.scopus.com/inward/record.url?scp=43049110969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049110969&partnerID=8YFLogxK

U2 - 10.1007/s00125-008-0987-y

DO - 10.1007/s00125-008-0987-y

M3 - Article

VL - 51

SP - 1046

EP - 1050

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -